Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.
J Health Commun. 2011 Jul;16(6):629-42. doi: 10.1080/10810730.2011.551995. Epub 2011 Jun 1.
Patients with rare illnesses may use medication information sources that are appreciably different from those used by patients with more common illnesses. This article's purpose is to describe vasculitis patients' most frequently used medication information sources, determine which sources patients perceive as credible, and explore gender differences in source use and perceived credibility. Using an online questionnaire, patients (n = 232) indicated how often they obtained medication information from 12 sources during the previous year and rated the credibility of 6 sources. The authors used multivariate analysis of covariance and follow-up contrasts to test for gender differences in source use and conducted t tests to compare patients' perceived credibility ratings. Patients used physicians and the Internet most often to obtain medication information and rated them as the most credible sources. Male patients used their spouse/partner more often and rated them as more credible than did female patients. Female patients were more likely to use medication package inserts and the Internet and were less likely to use nurses than were male patients. There appear to be similarities and differences between the information-seeking behaviors of vasculitis patients and other patient populations. Because male patients view their spouse/partner as a credible information source, providers may want to involve the spouse/partner in prescription decision making.
患有罕见疾病的患者可能会使用与更常见疾病患者明显不同的药物信息来源。本文的目的是描述血管炎患者最常使用的药物信息来源,确定患者认为哪些来源具有可信度,并探讨性别在来源使用和可信度感知方面的差异。研究人员使用在线问卷,让 232 名患者在过去一年中回答了他们从 12 个来源获取药物信息的频率,并对 6 个来源的可信度进行了评分。作者使用协方差多变量分析和后续对比来检验性别在来源使用方面的差异,并进行 t 检验比较患者对可信度的评价。患者最常从医生和互联网获取药物信息,并认为这两个来源最可信。男性患者比女性患者更常使用配偶/伴侣,并认为他们更可信。与男性患者相比,女性患者更有可能使用药物说明书和互联网,而不太可能使用护士。血管炎患者的信息搜索行为与其他患者群体之间似乎既有相似之处,也有不同之处。由于男性患者认为配偶/伴侣是一个可信的信息来源,因此提供者可能希望让配偶/伴侣参与处方决策。